What is MBX Biosciences, Inc.'s R&D?

MBX Biosciences, Inc. (MBX) reported R&D of $18.47M in Q1 2026.

How has MBX Biosciences, Inc.'s R&D changed year-over-year?

MBX Biosciences, Inc.'s R&D decreased by 17.5% year-over-year, from $22.41M to $18.47M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

MBX Biosciences, Inc. MBX R&D

R&D at other companies

Eli LillyLLY

$3.51B+28.4%

AmgenAMGN

$1.72B+15.7%

Viking TherapeuticsVKTX

$150.15M+263%

Amylyx Pharmaceuticals, Inc.AMLX

$27.61M+24.8%

BridgeBio PharmaBBIO

$126.64M+13.6%

Nurix Therapeutics, Inc.NRIX

$84.14M+20.8%

Other financials

Income statement

See full

Operating income-$27.3M-2.8%

Net income-$23.5M+1.5%

EPS (diluted)-$0.50+29.6%

Balance sheet

See full

Cash & equivalents$45.2M+51.2%

Total debt$555.0K+327%

Total equity$437.8M+85.9%

Total assets$452.7M+84.1%

Cash flow

See full

Operating cash flow-$20.2M+10.9%

CapEx$437.0K+1,357%

Free cash flow-$20.6M+9.1%

Valuation

See full

Market cap$2.21B+475%

Enterprise value$2.16B+533%

Returns & leverage

See full

Return on equity-25.7%—

Debt / equity0×0.0×

Current ratio30.8×+7.5×

Where this comes from

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MBX Biosciences, Inc.'s R&D?: MBX Biosciences, Inc. (MBX) reported R&D of $18.47M in Q1 2026.
How has MBX Biosciences, Inc.'s R&D changed year-over-year?: MBX Biosciences, Inc.'s R&D decreased by 17.5% year-over-year, from $22.41M to $18.47M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.